A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia

NCT07327359 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Androgenetic Alopecia (AGA)

Interventions

DRUG: OLX72021
DRUG: OLX72021
DRUG: OLX72021
DRUG: Placebo

Sponsor

Olix Pharmaceuticals, Inc.

Collaborators

[object Object]